Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiaoqiang Zhang
Observed name:
Zhang, Xiao-Qiang
Institutions:
Second Affiliated Hospital of Nanchang University,
Wuhan Sports University
Observed institutions:
Second Affiliated Hospital of Nanchang University,
Wuhan Sports University
ORCID:
0009-0000-7436-6695
Observed ORCID:
0009-0000-7436-6695
OpenAlex ID:
A5138634278
Associations between 24-hour movement behavior and non-suicidal self-injury in adolescents: based on compositional data and isotemporal substitution analysis
2026
·
Yingzhe Gao
, Xiaoqiang Zhang
, et al.
·
BMC Psychology
·
2
The Efficacy and Safety of Tislelizumab plus Anlotinib as First-line Treatment in Advanced Pulmonary Sarcomatoid Carcinoma: A Single-Arm Phase II Trial
2026
·
Zhimin Zeng
, Wenqian Huang
, et al.
·
Clinical Cancer Research
·
2
Figure S1,S2 and Table S1, S2 from The Efficacy and Safety of Tislelizumab plus Anlotinib as First-line Treatment in Advanced Pulmonary Sarcomatoid Carcinoma: A Single-Arm Phase II Trial
2026
·
Zhimin Zeng
, Wenqian Huang
, et al.
Data from The Efficacy and Safety of Tislelizumab plus Anlotinib as First-line Treatment in Advanced Pulmonary Sarcomatoid Carcinoma: A Single-Arm Phase II Trial
2026
·
Zhimin Zeng
, Wenqian Huang
, et al.
Retraction notice to “MiR-101–3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1” [Biomed. Pharmacother. 93 (2017), 1065–1073]
2026
·
Xiaoqiang Zhang
, Xianju He
, et al.
·
Biomedicine & Pharmacotherapy
Show more works
View as search
Works count:
8
Citation count:
4
H-index:
2
I10-index:
Year
Topic
Type